Locoregional Stomach Cancer
Gastrointestinal Stromal Tumor
Male, 69 years
Patient Internal ID: 272447331
ICD-10 code
C16.8 Malignant Neoplasm of Overlapping Sites of Stomach
Diagnosis (Incl. Metastases/Stage) and Year
August 2019
Gastrointestinal Stromal Tumor (GIST) ypT4N0(0/12)M0 R0 LV0.
Previous Treatment
Target Therapy (Imatinib), Surgery.
Prognosis and Survival Expectation
The prognosis remains good, the overall 5-year relative survival rate for a GIST in the United States is 85%.
Treatment Provided
Autologous DCV (10 doses) over a period of 16 months.
Patient Survival/Condition and Year
Date of Review: 02/01/2024
The patient has survived for 54 months since the diagnosis and has no signs of disease. It can be concluded that the addition of Immunotherapy, alongside Target Therapy and Surgery, has benefited in disease stabilisation so far.
